Endocannabinoid System Research: First-Episode Psychosis
Clinical Takeaway People experiencing first-episode psychosis have elevated rates of criminal legal involvement, with certain factors like substance use and aggressive behavior identifiable as predictors at initial presentation. Understanding these…
Endocannabinoid System Clinical Research Evidence
Clinical Takeaway People experiencing their first episode of psychosis have elevated rates of criminal legal involvement that correlate with psychotic symptom severity, substance use, and untreated illness duration. Early intervention programs and…
`Cannabis-Induced Psychosis and Psychotic Disorders: Key Evidence`
Clinical Takeaway A significant proportion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign that…
Endocannabinoid System Clinical Research: REAL 2.0 Findings
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image concerns and disordered eating patterns influence mental health, eating disorders, and substance use into early adulthood.…